XML 113 R103.htm IDEA: XBRL DOCUMENT v3.25.3
Earnings per share - Summary of earnings per share (Detail) - AUD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2023
Earnings per share [abstract]      
Loss after income tax attributable to the owners of Kazia Therapeutics Limited $ (20,702) $ (26,778) $ (20,465)
Loss after income tax attributable to the owners of Kazia Therapeutics Limited $ (20,702) $ (26,778) $ (20,465)
Weighted average number of ordinary shares used in calculating basic and diluted earnings per share 547,941,171 263,676,313 184,284,350
Basic earnings per share $ (0.0378) $ (0.1016) $ (0.1123)
Diluted earnings per share $ (0.0378) $ (0.1016) $ (0.1123)